查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095366

放射治療設備市場－2026-2032年全球市場預測

Radiation Therapy Equipment Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，放射治療設備市場規模將達到 127 億美元，複合年成長率為 7.63%。

主要市場統計數據
基準年 2025 75.9億美元
預計年份：2026年 81.4億美元
預測年份 2032 127億美元
複合年成長率 (%) 7.63%

放射治療設備執行摘要

放射治療設備是現代腫瘤學的核心，它能夠透過遠距照射、近距離放射、立體定位放射放射線手術、質子治療、影像導航放射治療、強度調控放射治療和局部放射治療等多種方式實現局部癌症治療。全球癌症負擔、人口老化、篩檢計畫的擴展以及為日益複雜的腫瘤類型提供精準、安全且可重複治療的需求，共同推動了放射治療設備的需求成長。根據國際癌症監測機構的數據，癌症仍然是全球主要死因之一，這凸顯了便捷的放射治療基礎設施以及訓練有素的醫學物理學家、放射腫瘤學家、劑量師和放射治療技師的臨床重要性。

放射治療設備領域的變革性變化

在放射治療設備領域，一場結構性變革正在進行，治療方式正從傳統療法轉向精準腫瘤治療平台，這些平台融合了先進的影像技術、軟體驅動的智慧系統、運動管理和自適應治療功能。儘管基於直線線性加速器的系統仍然是體外放射治療的核心，但立體定位部分放射治療（SBRT）和立體定位放射線手術（SRS）由於能夠以更少的分次劑量提供高度適形的照射，在某些適應症中正日益受到重視。質子束和粒子束療法在兒童癌症和解剖結構敏感的腫瘤治療中持續受到關注，因為在這些情況下，劑量降低具有重要的臨床意義，但這些療法的應用取決於基礎設施、保險報銷、熟練的醫務人員以及長期的臨床證據。

人工智慧對放射治療設備的累積影響

人工智慧（AI）正累積滲透到放射治療設備的整個價值鏈，其應用範圍涵蓋影像診斷、勾畫靶區、治療計劃、劑量計算輔助、病患定位、品質保證、工作流程最佳化以及治療結果分析等。在專家進行適當的臨床審核後，人工智慧驅動的自動勾畫靶區可以減少重複性的人工操作，並提高關鍵器官和標靶可視化的一致性。基於機器學習的治療計劃也被用於產生治療計劃草案、最佳化劑量分佈以及規範不同醫療機構之間的治療方案。

全球放射治療設備部署的關鍵區域性見解

亞太地區正發展成為放射治療設備領域最具活力的地區之一，這主要得益於癌症發病率的上升、醫療基礎設施的不斷完善以及各國政府為改善都市區醫療中心癌症治療服務可及性所做的努力。中國、印度、日本、韓國、澳洲和東南亞國協的醫療系統都在增加對放射治療能力、數位化治療計畫和專科醫生培訓的投入，但大都會醫院與服務不足地區之間仍然存在醫療資源分配不均的問題。日本和韓國在採用先進的影像導引和立體定位放射治療技術方面取得了顯著進展，而印度和東南亞國家則繼續致力於擴大服務覆蓋範圍、提高成本效益和培養人力資源。

影響放射治療設備策略的關鍵產業趨勢

北約成員國與北美和歐洲許多先進的醫療市場重疊，這些市場的放射治療基礎設施與具有韌性的醫療保健系統、網路安全要求、醫療設備法規和標準化的緊急應變密切相關。七國集團（G7）國家的醫療保健系統成熟，在安全性、臨床證據和技術評估方面均達到高標準。在這些國家，自適應放射治療、立體定位放射治療、工作流程自動化、基礎設施現代化和生命週期成本管理是優先事項。

主要國家關於引進放射治療設備的見解

美國憑藉其大規模的腫瘤醫療網路、活躍的臨床試驗以及影像導引、立體定位和自適應治療流程的廣泛應用，仍然是先進放射治療設備的主要市場。在加拿大，公平地獲得癌症治療、省級規劃以及公共醫療體系的品質保證是重中之重。墨西哥正透過公私投資相結合的方式推動腫瘤服務的現代化，重點在於確保主要都會區以外的地區也能獲得治療。巴西是拉丁美洲的放射治療中心，公共部門的可用性、地理分佈和維護支持都是重要的考量。

為放射治療設備行業的領導者提供的實用建議

產業領導者必須將放射治療設備的策略與臨床價值、營運韌性和長期服務表現相結合。技術選擇不應僅檢驗功能比較，還應基於已驗證的臨床需求、預期患者群體、治療複雜性、人員配備、互通性和品質保證要求。醫療機構應評估設備是否支援目前和未來的工作流程，包括影像導航放射治療、立體定位放射治療、低分割放射治療、自適應計畫和遠距計畫協作。

深入了解放射治療設備的調查方法

本執行摘要採用系統化的二手研究途徑編寫，重點關注來自醫學、腫瘤學、監管和臨床實踐領域權威資訊來源的經檢驗且有數據支持的資訊。該調查方法包括對全球癌症負擔數據、放射治療可及性、輻射防護指南、醫療設備法規結構、臨床實踐指南以及影像導航放射治療、立體定位放射治療、自適應放射治療、質子治療和人工智慧輔助放射腫瘤學工作流程等方面的同行評審文獻進行審查。

結論：提高放射治療設備的準確性、易用性和安全性。

放射治療設備正步入一個新階段，其特點是面臨精準照射、影像融合、人工智慧、自適應工作流程以及擴大癌症治療公平獲取途徑等諸多緊迫挑戰。該領域的進步不再僅僅取決於設備本身的性能，還取決於系統與臨床方案、數位基礎設施、品質保證系統、專業人員以及永續服務模式的有效整合程度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：放射治療設備市場：依產品類型分類

  • 外部照射裝置
    • 直線加速器
    • 立體定位放射治療系統
    • 螺旋斷層放射治療系統
    • 機器人輔助放射外科系統
  • 體內放射治療裝置（近距離放射治療）

第8章：放射治療設備市場：依放射類型分類

  • 光子束
  • 質子束
  • 電子束
  • 中子束
  • 基於同位素的放射療法
  • α/BETA粒子

第9章 放射治療設備市場：依應用領域分類

  • 大腦和神經系統
  • 乳癌
  • 肺
  • 攝護腺
  • 子宮頸癌/婦科癌症
  • 胃腸道癌症

第10章：放射治療設備市場：依最終用戶分類

  • 門診手術中心
  • 癌症研究中心
  • 醫院

第11章：放射治療設備市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第12章：放射治療設備市場：依類別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第13章：放射治療設備市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 法國
  • 加拿大
  • 巴西
  • 義大利
  • 墨西哥
  • 澳洲
  • 韓國
  • 俄羅斯
  • 西班牙

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Siemens Healthineers AG
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Ion Beam Applications SA
  • Hitachi, Ltd.
  • RefleXion Medical, Inc.
  • Nordion by Sotera Health LLC
  • Mevion Medical Systems, Inc.
  • Bionix LLC
  • Accuray Incorporated
  • Allengers Medical Systems Ltd
  • BEBIG Medical GmbH
  • BrainLab AG
  • Canon Inc.
  • Carl Zeiss AG
  • China Isotope & Radiation Corporation
  • Eckert and Ziegler AG
  • IntraOp Medical Corp.
  • Klarity Medical & Equipment（GZ）Co., Ltd.
  • Koninklijke Philips NV
  • LINEV Group
  • MinXray, Inc.
  • Mitsubishi Heavy Industries, Ltd.
  • Oraya Therapeutics Inc.
  • PTW Freiburg GmbH
  • Stryker Corporation
  • Sumitomo Heavy Industries, Ltd.
  • Xstrahl Group
Product Code: MRR-02026C4C95C5

The Radiation Therapy Equipment Market is projected to grow by USD 12.70 billion at a CAGR of 7.63% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.59 billion
Estimated Year [2026] USD 8.14 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 7.63%

Radiation Therapy Equipment Executive Summary

Radiation therapy equipment is a core pillar of modern oncology, enabling localized cancer treatment through external beam radiotherapy, brachytherapy, stereotactic radiosurgery, proton therapy, image-guided radiotherapy, intensity-modulated radiotherapy, and adaptive radiotherapy workflows. Demand is being shaped by the global cancer burden, aging populations, expanding screening programs, and the need to deliver precise, safe, and repeatable treatment across increasingly complex tumor types. According to international cancer surveillance agencies, cancer remains one of the leading causes of death worldwide, reinforcing the clinical importance of accessible radiotherapy infrastructure, trained medical physicists, radiation oncologists, dosimetrists, and oncology technologists.

The radiation therapy equipment landscape is moving beyond hardware replacement cycles toward integrated oncology ecosystems. Treatment systems are now evaluated not only by beam delivery performance but also by imaging quality, patient positioning accuracy, treatment planning interoperability, quality assurance automation, cybersecurity readiness, uptime, serviceability, and compatibility with hospital information systems. Healthcare providers are prioritizing equipment that improves precision, shortens treatment sessions, supports hypofractionated regimens, and helps reduce toxicity to surrounding healthy tissue.

Regulatory agencies and clinical societies continue to emphasize patient safety, radiation dose optimization, peer-reviewed treatment planning, and robust quality management. As a result, purchasing decisions increasingly depend on evidence-based clinical utility, lifecycle service support, workforce training, and the ability to standardize care across multi-site oncology networks. These factors make radiation therapy equipment a strategically important segment within cancer care modernization.

Transformative Shifts in the Radiation Therapy Equipment Landscape

The radiation therapy equipment landscape is undergoing a structural shift from conventional treatment delivery toward precision oncology platforms that combine advanced imaging, software intelligence, motion management, and adaptive treatment capabilities. Linear accelerator-based systems remain central to external beam radiotherapy, while stereotactic body radiotherapy and stereotactic radiosurgery are gaining clinical relevance for selected indications due to their ability to deliver highly conformal doses in fewer fractions. Proton therapy and particle therapy continue to attract attention for pediatric cancers and anatomically sensitive tumors where dose sparing is clinically meaningful, although adoption depends on infrastructure, reimbursement, skilled staffing, and long-term clinical evidence.

Another transformative shift is the growing importance of image guidance and real-time treatment verification. Cone-beam CT, MRI-guided radiotherapy, surface-guided radiotherapy, respiratory gating, and adaptive planning are helping clinicians address tumor motion, anatomical changes, and organ-at-risk constraints. These capabilities support more personalized radiation treatment and strengthen confidence in dose delivery accuracy.

Operational transformation is equally significant. Oncology centers are seeking shorter simulation-to-treatment timelines, automated contouring, streamlined plan review, remote quality assurance, and centralized treatment planning for distributed networks. The shift toward value-based healthcare is also increasing scrutiny on equipment utilization, treatment throughput, maintenance costs, energy efficiency, and service response. As radiation oncology becomes more digitally connected, cybersecurity, data governance, and interoperability with electronic health records and oncology information systems are now essential procurement considerations rather than optional features.

Cumulative Impact of Artificial Intelligence on Radiation Therapy Equipment

Artificial intelligence is becoming a cumulative force across the radiation therapy equipment value chain, with applications spanning imaging, contouring, treatment planning, dose calculation support, patient positioning, quality assurance, workflow orchestration, and outcomes analysis. AI-assisted auto-contouring can reduce repetitive manual tasks and improve consistency in delineating organs at risk and target volumes, provided outputs remain under expert clinical review. Machine learning-supported treatment planning is also being used to generate plan candidates, optimize dose distributions, and help standardize protocols across institutions.

In equipment operation, AI-enabled image registration, motion assessment, and adaptive radiotherapy decision support can help clinicians evaluate daily anatomical variation and determine whether treatment modification is warranted. Predictive maintenance tools are also being integrated into service models to monitor machine performance, detect anomalies, and reduce unplanned downtime, which is particularly important for high-volume cancer centers with tightly scheduled treatment slots.

The impact of AI is cumulative because it compounds across the patient journey: faster simulation, more consistent planning, improved treatment verification, and better operational visibility. However, adoption must be governed by validated algorithms, transparent performance testing, bias monitoring, regulatory compliance, audit trails, and human-in-the-loop decision-making. In radiation oncology, AI should augment clinical expertise rather than replace professional judgment, especially where dose delivery decisions carry direct patient safety implications. Institutions that combine AI with robust governance, multidisciplinary training, and standardized quality assurance are positioned to gain the greatest workflow and care-quality benefits.

Key Regional Insights Across Global Radiation Therapy Equipment Adoption

Asia-Pacific is advancing as one of the most dynamic regions for radiation therapy equipment due to rising cancer incidence, healthcare infrastructure expansion, and government efforts to improve oncology access across urban and regional centers. China, India, Japan, South Korea, Australia, and ASEAN health systems are investing in radiotherapy capacity, digital treatment planning, and specialist training, although access gaps remain between major metropolitan hospitals and underserved areas. Japan and South Korea demonstrate strong adoption of advanced image-guided and stereotactic techniques, while India and Southeast Asian countries continue to focus on expanding availability, affordability, and workforce development.

Europe benefits from established cancer networks, cross-border clinical collaboration, and strong safety frameworks, with European Union policies supporting harmonized healthcare quality initiatives, radiation protection standards, and cancer control programs. Germany, France, Italy, Spain, and the United Kingdom continue to focus on advanced techniques, replacement of aging infrastructure, treatment pathway optimization, and consistent quality assurance across public and academic oncology systems.

North America is characterized by mature radiation oncology infrastructure, strong clinical protocol standardization, high use of advanced external beam radiotherapy, and broad adoption of digital oncology workflows. The United States and Canada emphasize precision treatment, multidisciplinary cancer centers, accreditation, and rigorous quality assurance. Reimbursement policy, clinical evidence, and staffing availability remain important determinants of equipment utilization and technology upgrades.

Latin America shows growing interest in modern radiotherapy systems as cancer control programs seek to reduce treatment access disparities. Brazil and Mexico are key contributors to regional modernization, but equipment distribution, public-sector funding, maintenance capacity, and trained workforce availability influence implementation speed. The Middle East is expanding oncology capacity through hospital development, specialist centers, and increasing adoption of precision radiotherapy in Gulf economies, where digital health integration and workforce localization are key priorities. Africa faces the most significant radiotherapy access challenges, with international health agencies documenting shortages of equipment, trained personnel, and maintenance support in many countries. Regional priorities include expanding basic radiotherapy access, strengthening cancer registries, building medical physics capacity, and creating sustainable service models that can operate reliably in resource-constrained settings.

Key Group Insights Shaping Radiation Therapy Equipment Strategies

NATO countries overlap with many advanced healthcare markets in North America and Europe, where radiotherapy infrastructure is closely tied to resilient health systems, cybersecurity expectations, medical device regulation, and standardized emergency preparedness. The G7 group reflects mature healthcare systems with high standards for safety, clinical evidence, and technology assessment. In these countries, priorities include adaptive radiotherapy, stereotactic treatment, workflow automation, infrastructure renewal, and lifecycle cost control.

The European Union provides a highly regulated and quality-focused environment for radiotherapy, supported by radiation protection directives, cancer policy initiatives, and collaborative research networks. EU health systems are focused on evidence-based equipment adoption, interoperability, safety audits, and equitable access to modern cancer treatment. BRICS countries represent a diverse set of radiation therapy equipment opportunities and challenges. China and India are expanding radiotherapy capacity for large patient populations, Brazil and South Africa are working to address access inequities, and Russia maintains significant oncology infrastructure with ongoing modernization needs.

ASEAN is becoming increasingly relevant in radiation therapy equipment planning as member countries expand cancer control capacity and address rising demand for oncology services. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines show different levels of infrastructure maturity, making regional strategy dependent on public procurement priorities, private hospital investment, workforce training, and service support. Across ASEAN, the emphasis is on improving access to external beam radiotherapy, strengthening treatment planning expertise, and deploying technologies suitable for high-throughput clinical environments.

The GCC is prioritizing oncology modernization through advanced hospital infrastructure, specialist cancer centers, and digital transformation in healthcare delivery. Radiation therapy equipment procurement in this group is often linked to national health strategies, local clinical capability building, and efforts to reduce outbound medical travel. Across these country groups, successful radiation therapy equipment strategies depend on aligning technology selection with clinical capacity, workforce availability, maintenance ecosystems, reimbursement conditions, and national cancer control objectives.

Key Country Insights for Radiation Therapy Equipment Deployment

The United States remains a leading environment for advanced radiation therapy equipment due to its large oncology care network, clinical trial activity, and adoption of image-guided, stereotactic, and adaptive treatment workflows. Canada emphasizes equitable cancer care access, provincial planning, and quality assurance across public healthcare systems. Mexico is modernizing oncology services through a mix of public and private investment, with attention to access outside major urban centers. Brazil is central to Latin American radiotherapy capacity, where public-sector availability, regional distribution, and maintenance support are important considerations.

China is rapidly expanding cancer care infrastructure and increasing domestic radiotherapy capacity to meet a large oncology burden, with significant attention to hospital modernization, local manufacturing capability, and training. India faces high demand and persistent access gaps, making scalable, reliable, and cost-effective radiation therapy equipment essential for both public and private cancer centers. Japan has mature oncology capabilities and strong adoption of precision radiotherapy techniques, including stereotactic and particle therapy for selected clinical use cases. Australia emphasizes centralized quality standards, regional access, and advanced treatment capability in major cancer centers. South Korea combines high technology adoption with strong hospital digitalization, supporting image-guided radiotherapy, stereotactic treatment, and integrated oncology workflows.

Germany has a strong radiation oncology base supported by specialized clinical centers and engineering expertise, while the United Kingdom continues to prioritize cancer pathway improvement, equipment replacement, and national quality standards. France emphasizes protocol-driven care, radiation protection, and integration of radiotherapy into comprehensive cancer networks. Italy and Spain show established radiotherapy capabilities, with interest in advanced planning, image guidance, and efficient treatment delivery within publicly oriented health systems. Russia maintains broad oncology infrastructure and faces ongoing needs for modernization, regional access, and workforce development.

Actionable Recommendations for Radiation Therapy Equipment Industry Leaders

Industry leaders should align radiation therapy equipment strategies with clinical value, operational resilience, and long-term service performance. Technology selection should be based on validated clinical need, expected patient mix, treatment complexity, staffing capacity, interoperability, and quality assurance requirements rather than feature comparison alone. Providers should assess whether equipment supports current and future workflows such as image-guided radiotherapy, stereotactic treatment, hypofractionation, adaptive planning, and remote planning collaboration.

Organizations should invest in workforce readiness before commissioning new systems. Radiation oncologists, medical physicists, dosimetrists, therapists, biomedical engineers, and IT teams need structured training on treatment planning, safety checks, imaging protocols, cybersecurity, and downtime procedures. Procurement teams should evaluate lifecycle service agreements, spare parts availability, software upgrade pathways, uptime commitments, and local technical support.

For manufacturers and technology developers, priorities should include workflow simplification, AI validation, open interoperability, secure data exchange, and equipment designs that can serve both advanced cancer centers and resource-constrained environments. For healthcare systems, the most actionable path is to pair equipment investment with cancer registry strengthening, referral pathway improvement, maintenance planning, and standardized quality assurance programs. Leaders that integrate clinical governance, digital readiness, and sustainable service models will be better positioned to improve radiotherapy access, safety, and treatment consistency.

Research Methodology for Radiation Therapy Equipment Insights

This executive summary is developed through a structured secondary research approach focused on verified, data-backed information from authoritative healthcare, oncology, regulatory, and clinical sources. The methodology includes reviewing global cancer burden data, radiotherapy access publications, radiation protection guidance, medical device regulatory frameworks, clinical practice recommendations, and peer-reviewed literature on image-guided radiotherapy, stereotactic radiotherapy, adaptive radiotherapy, proton therapy, and AI-enabled radiation oncology workflows.

The analysis emphasizes qualitative market intelligence rather than market sizing or forecasting. Regional, group, and country insights are synthesized by assessing cancer care infrastructure, policy direction, technology adoption patterns, workforce availability, reimbursement environment, radiotherapy access gaps, and quality assurance standards. The approach also considers practical procurement factors such as lifecycle maintenance, interoperability, cybersecurity, training requirements, and operational continuity.

To ensure relevance for executive decision-making, the research framework prioritizes evidence triangulation across public health agencies, international oncology organizations, regulatory bodies, academic publications, and recognized clinical guidelines. Insights are interpreted through the lens of equipment deployment, treatment workflow transformation, and healthcare system readiness, while avoiding unsupported claims and excluding speculative projections.

Conclusion: Advancing Precision, Access, and Safety in Radiation Therapy Equipment

Radiation therapy equipment is entering a new phase defined by precision delivery, imaging integration, artificial intelligence, adaptive workflows, and the urgent need to expand equitable cancer treatment access. The sector's evolution is no longer limited to equipment performance; it now depends on how effectively systems integrate with clinical protocols, digital infrastructure, quality assurance programs, trained workforces, and sustainable service models.

Regional conditions vary significantly. Mature markets are prioritizing treatment personalization, automation, and infrastructure renewal, while emerging and underserved regions are focused on expanding basic radiotherapy access and building durable clinical capacity. Across all settings, the central objective remains consistent: deliver safe, accurate, timely, and evidence-based radiation treatment to patients who need it.

Industry leaders that combine validated technology, AI governance, workforce development, cybersecurity, and lifecycle support will be best positioned to advance radiation oncology. As cancer care systems continue to modernize, radiation therapy equipment will remain essential to improving treatment precision, operational efficiency, and patient-centered oncology outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Radiation Therapy Equipment Market, by Product Type

  • 7.1. Introduction
  • 7.2. External Beam Radiation Therapy Device
    • 7.2.1. Linear Accelerators
    • 7.2.2. Stereotactic Systems
    • 7.2.3. Tomotherapy Systems
    • 7.2.4. Robotic Radiosurgery Systems
  • 7.3. Internal Beam Radiation Therapy Device (Brachytherapy)

8. Radiation Therapy Equipment Market, by Radiation Type

  • 8.1. Introduction
  • 8.2. Photon Beam
  • 8.3. Proton Beam
  • 8.4. Electron Beam
  • 8.5. Neutron Beam
  • 8.6. Isotope-Based Radiation
  • 8.7. Alpha / Beta Particle

9. Radiation Therapy Equipment Market, by Application

  • 9.1. Introduction
  • 9.2. Brain And Nervous System
  • 9.3. Breast
  • 9.4. Lung
  • 9.5. Prostate
  • 9.6. Cervical / Gynecological Cancer
  • 9.7. Gastrointestinal Cancer

10. Radiation Therapy Equipment Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Cancer Research Centers
  • 10.4. Hospitals

11. Radiation Therapy Equipment Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. Europe
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Africa
  • 11.6. Middle East

12. Radiation Therapy Equipment Market, by Group

  • 12.1. NATO
  • 12.2. G7
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. ASEAN
  • 12.6. GCC

13. Radiation Therapy Equipment Market, by Country

  • 13.1. United States
  • 13.2. China
  • 13.3. Germany
  • 13.4. Japan
  • 13.5. India
  • 13.6. United Kingdom
  • 13.7. France
  • 13.8. Canada
  • 13.9. Brazil
  • 13.10. Italy
  • 13.11. Mexico
  • 13.12. Australia
  • 13.13. South Korea
  • 13.14. Russia
  • 13.15. Spain

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Siemens Healthineers AG
  • 15.2. Elekta AB
  • 15.3. GE HealthCare Technologies Inc.
  • 15.4. Ion Beam Applications S.A.
  • 15.5. Hitachi, Ltd.
  • 15.6. RefleXion Medical, Inc.
  • 15.7. Nordion by Sotera Health LLC
  • 15.8. Mevion Medical Systems, Inc.
  • 15.9. Bionix LLC
  • 15.10. Accuray Incorporated
  • 15.11. Allengers Medical Systems Ltd
  • 15.12. BEBIG Medical GmbH
  • 15.13. BrainLab AG
  • 15.14. Canon Inc.
  • 15.15. Carl Zeiss AG
  • 15.16. China Isotope & Radiation Corporation
  • 15.17. Eckert and Ziegler AG
  • 15.18. IntraOp Medical Corp.
  • 15.19. Klarity Medical & Equipment (GZ) Co., Ltd.
  • 15.20. Koninklijke Philips N.V.
  • 15.21. LINEV Group
  • 15.22. MinXray, Inc.
  • 15.23. Mitsubishi Heavy Industries, Ltd.
  • 15.24. Oraya Therapeutics Inc.
  • 15.25. PTW Freiburg GmbH
  • 15.26. Stryker Corporation
  • 15.27. Sumitomo Heavy Industries, Ltd.
  • 15.28. Xstrahl Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTERNAL BEAM RADIATION THERAPY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTERNAL BEAM RADIATION THERAPY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTERNAL BEAM RADIATION THERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LINEAR ACCELERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LINEAR ACCELERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LINEAR ACCELERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STEREOTACTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STEREOTACTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STEREOTACTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TOMOTHERAPY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TOMOTHERAPY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TOMOTHERAPY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC RADIOSURGERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC RADIOSURGERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC RADIOSURGERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERNAL BEAM RADIATION THERAPY DEVICE (BRACHYTHERAPY) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHOTON BEAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHOTON BEAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHOTON BEAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROTON BEAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROTON BEAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROTON BEAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELECTRON BEAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELECTRON BEAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELECTRON BEAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUTRON BEAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUTRON BEAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUTRON BEAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOTOPE-BASED RADIATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOTOPE-BASED RADIATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ISOTOPE-BASED RADIATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ALPHA / BETA PARTICLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALPHA / BETA PARTICLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ALPHA / BETA PARTICLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN AND NERVOUS SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN AND NERVOUS SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN AND NERVOUS SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BREAST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LUNG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LUNG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LUNG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROSTATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PROSTATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROSTATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CERVICAL / GYNECOLOGICAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CERVICAL / GYNECOLOGICAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CERVICAL / GYNECOLOGICAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL CANCER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CANCER RESEARCH CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANCER RESEARCH CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CANCER RESEARCH CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 111. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NATO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 117. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. G7 RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GCC RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 160. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GERMANY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 166. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. JAPAN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 172. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. INDIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED KINGDOM RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 184. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. FRANCE RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 196. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRAZIL RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. ITALY RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 208. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. MEXICO RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 214. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. AUSTRALIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 220. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. SOUTH KOREA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 226. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. RUSSIA RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY EXTERNAL BEAM RADIATION THERAPY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 232. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY RADIATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. SPAIN RADIATION THERAPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL RADIATION THERAPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 236. GLOBAL RADIATION THERAPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025